Amyloid-β peptide: Dr. Jekyll or Mr. Hyde?

Area of Science:

• Neuroscience
• Molecular Biology
• Pathology

Background:

• Amyloid-beta (Aβ) peptides are implicated in Alzheimer's disease (AD) pathogenesis due to neurotoxicity and plaque formation.
• Aβ originates from the amyloid-beta protein precursor (AβPP), whose processing yields various Aβ fragments.
• The physiological function of AβPP and its fragments, particularly Aβ, is not well understood, with Aβ often considered a toxic byproduct.

Purpose of the Study:

• To investigate the potential physiological role of Aβ in the healthy brain.
• To determine if Aβ concentrations are necessary for normal synaptic plasticity and memory.
• To explore the mechanisms underlying Aβ's effects on neurotransmission and cognitive function.

Main Methods:

• Administered picomolar concentrations of human Aβ42 to mice to assess effects on synaptic plasticity and memory.
• Utilized an anti-rodent Aβ antibody and siRNA against murine AβPP to reduce endogenous Aβ levels in healthy mice.
• Investigated the role of neurotransmitter release and α7-nicotinic receptors in mediating Aβ's effects.

Main Results:

• Picomolar Aβ42 enhanced synaptic plasticity and memory in mice.
• Inhibition of endogenous Aβ production in mice impaired synaptic plasticity and memory.
• Administration of human Aβ42 rescued deficits caused by reduced endogenous Aβ.
• Aβ's effects were mediated by modulating neurotransmitter release and α7-nicotinic receptors.

Conclusions:

• Physiological concentrations of Aβ are necessary for normal synaptic plasticity and memory in the healthy brain.
• Aβ is not merely a toxic "garbage" fragment but plays a crucial physiological role.
• Findings necessitate re-evaluation of therapeutic strategies for Alzheimer's disease, considering Aβ's normal function.